CORE
šŗš¦Ā
Ā make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Predictive Value for Event-Free Survival of Interim 18F-FDG-PET In Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with 6 Cycles of Dose-Dense R-CHOP-14 Immunochemotherapy Plus Pegfilgrastim as First-Line Treatment: An Open-Label Clinical Trial In Spain.
Author
Albert Oriol
AndreĢs Llorente
+13Ā more
AndreĢs LoĢpez
Antonio Salar
Dolores Caballero
Eva Donato
Eva GonzaĢlez-Barca
Joan Bargay
JoseĢ Francisco TomaĢs
JoseĢ Javier SaĢnchez
Juan Coya
MariĢa JesuĢs Vidal
Miguel Canales
Montse CorteĢs
Secundino Ferrer
Publication venue
'American Society of Hematology'
Publication date
Field of study
No full text
Crossref